Deutsch
Čeština
Français
Italiano
العربية
Español
* For illustration purpose only
Trinex (Triclabendazole)
Not in stock
Category:
Other
Commercial Name: Trinex Active Ingredient: Triclabendazole
Utilization: Used to treat liver flukes, specifically fascioliasis and paragonimiasis
Available Dosages: 2mg
Delivery information
No delivery to USA
* Prices in the list do not apply to Switzerland, Sweden and Denmark. Customers are advised to place an order, and our team will contact back with updated prices.
There are 4 users looking at this product right now
Description
Triclabendazole, manufactured by Novartis pharmaceuticals, is an antihelminthic drug that was approved by the FDA in February 2019 for the treatment of fascioliasis in humans. Fascioliasis is a parasitic infection often caused by the helminth, Fasciola hepatica, which is also known as “the common liver fluke” or “the sheep liver fluke” or by Fasciola gigantica, another helminth. These parasites can infect humans following ingestion of larvae in contaminated water or food.
Triclabendazole was previously used in the treatment of fascioliasis in livestock, but is now approved for human use. This drug is currently the only FDA-approved drug for individuals with fascioliasis, which affects 2.4 million people worldwide
Medically reviewed by Dr. Josette Davignon
Last updated: 15.04.2024
Write your review
